FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965335179> ?p ?o ?g. }

• W1965335179 abstract "Patients with ER-negative breast tumors are among the most difficult to treat and exhibit low survival rates due, in part, to metastasis from the breast to various distal sites. Aryl hydrocarbon receptor (AHR) ligands show promise as antimetastatic drugs for estrogen receptor (ER)-negative breast cancer. Triple negative MDA-MB-231 breast cancer cells were treated with eight AHR-active pharmaceuticals including 4-hydroxtamoxifen, flutamide leflunomide, mexiletine, nimodipine, omeprazole, sulindac and tranilast, and the effects of these compounds on cell proliferation (MTT assay) and cell migration (Boyden chamber assay) were examined. The role of the AHR in mediating inhibition of MDA-MB-231 cell invasion was investigated by RNA interference (RNAi) and knockdown of AHR or cotreatment with AHR agonists. Lung metastasis of MDA-MB-231 cells was evaluated in mice administered cells by tail vein injection and prometastatic gene expression was examined by immunohistochemistry. We showed that only the proton pump inhibitor omeprazole decreased MDA-MB-231 breast cancer cell invasion in vitro. Omeprazole also significantly decreased MDA-MB-231 cancer cell metastasis to the lung in a mouse model (tail vein injection), and in vitro studies showed that omeprazole decreased expression of at least two prometastatic genes, namely matrix metalloproteinase-9 (MMP-9) and C-X-C chemokine receptor 4 (CXCR4). Results of RNA interference studies confirmed that omeprazole-mediated downregulation of CXCR4 (but not MMP-9) was AHR-dependent. Chromatin immunoprecipitation assays demonstrated that omeprazole recruited the AHR to regions in the CXCR4 promoter that contain dioxin response elements (DREs) and this was accompanied by the loss of pol II on the promoter and decreased expression of CXCR4. AHR-active pharmaceuticals such as omeprazole that decrease breast cancer cell invasion and metastasis may have important clinical applications for late stage breast cancer chemotherapy." @default.
• W1965335179 created "2016-06-24" @default.
• W1965335179 creator A5002549571 @default.
• W1965335179 creator A5036575223 @default.
• W1965335179 creator A5036752356 @default.
• W1965335179 creator A5065076784 @default.
• W1965335179 date "2014-07-09" @default.
• W1965335179 modified "2023-10-01" @default.
• W1965335179 title "The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis" @default.
• W1965335179 cites W1577296862 @default.
• W1965335179 cites W1933952629 @default.
• W1965335179 cites W1935479846 @default.
• W1965335179 cites W1970035334 @default.
• W1965335179 cites W1973927114 @default.
• W1965335179 cites W1975507174 @default.
• W1965335179 cites W1980214543 @default.
• W1965335179 cites W1988502442 @default.
• W1965335179 cites W1993003564 @default.
• W1965335179 cites W1994110859 @default.
• W1965335179 cites W1998004896 @default.
• W1965335179 cites W2004522121 @default.
• W1965335179 cites W2007193116 @default.
• W1965335179 cites W2015472059 @default.
• W1965335179 cites W2022422705 @default.
• W1965335179 cites W2025605750 @default.
• W1965335179 cites W2025902090 @default.
• W1965335179 cites W2035410400 @default.
• W1965335179 cites W2036295703 @default.
• W1965335179 cites W2039389146 @default.
• W1965335179 cites W2040568539 @default.
• W1965335179 cites W2051991793 @default.
• W1965335179 cites W2062677449 @default.
• W1965335179 cites W2063200097 @default.
• W1965335179 cites W2070148500 @default.
• W1965335179 cites W2071135820 @default.
• W1965335179 cites W2076927594 @default.
• W1965335179 cites W2084168389 @default.
• W1965335179 cites W2091788788 @default.
• W1965335179 cites W2104824311 @default.
• W1965335179 cites W2109541969 @default.
• W1965335179 cites W2118744236 @default.
• W1965335179 cites W2119528383 @default.
• W1965335179 cites W2119965437 @default.
• W1965335179 cites W2130538892 @default.
• W1965335179 cites W2132492539 @default.
• W1965335179 cites W2147140209 @default.
• W1965335179 cites W2156195812 @default.
• W1965335179 cites W2161713280 @default.
• W1965335179 cites W2166818031 @default.
• W1965335179 cites W2333659151 @default.
• W1965335179 doi "https://doi.org/10.1186/1471-2407-14-498" @default.
• W1965335179 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4226953" @default.
• W1965335179 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25011475" @default.
• W1965335179 hasPublicationYear "2014" @default.
• W1965335179 type Work @default.
• W1965335179 sameAs 1965335179 @default.
• W1965335179 citedByCount "108" @default.
• W1965335179 countsByYear W19653351792014 @default.
• W1965335179 countsByYear W19653351792015 @default.
• W1965335179 countsByYear W19653351792016 @default.
• W1965335179 countsByYear W19653351792017 @default.
• W1965335179 countsByYear W19653351792018 @default.
• W1965335179 countsByYear W19653351792019 @default.
• W1965335179 countsByYear W19653351792020 @default.
• W1965335179 countsByYear W19653351792021 @default.
• W1965335179 countsByYear W19653351792022 @default.
• W1965335179 countsByYear W19653351792023 @default.
• W1965335179 crossrefType "journal-article" @default.
• W1965335179 hasAuthorship W1965335179A5002549571 @default.
• W1965335179 hasAuthorship W1965335179A5036575223 @default.
• W1965335179 hasAuthorship W1965335179A5036752356 @default.
• W1965335179 hasAuthorship W1965335179A5065076784 @default.
• W1965335179 hasBestOaLocation W19653351791 @default.
• W1965335179 hasConcept C104317684 @default.
• W1965335179 hasConcept C121608353 @default.
• W1965335179 hasConcept C126322002 @default.
• W1965335179 hasConcept C185592680 @default.
• W1965335179 hasConcept C2775975398 @default.
• W1965335179 hasConcept C2779013556 @default.
• W1965335179 hasConcept C33594762 @default.
• W1965335179 hasConcept C502942594 @default.
• W1965335179 hasConcept C55493867 @default.
• W1965335179 hasConcept C71924100 @default.
• W1965335179 hasConcept C86339819 @default.
• W1965335179 hasConceptScore W1965335179C104317684 @default.
• W1965335179 hasConceptScore W1965335179C121608353 @default.
• W1965335179 hasConceptScore W1965335179C126322002 @default.
• W1965335179 hasConceptScore W1965335179C185592680 @default.
• W1965335179 hasConceptScore W1965335179C2775975398 @default.
• W1965335179 hasConceptScore W1965335179C2779013556 @default.
• W1965335179 hasConceptScore W1965335179C33594762 @default.
• W1965335179 hasConceptScore W1965335179C502942594 @default.
• W1965335179 hasConceptScore W1965335179C55493867 @default.
• W1965335179 hasConceptScore W1965335179C71924100 @default.
• W1965335179 hasConceptScore W1965335179C86339819 @default.
• W1965335179 hasIssue "1" @default.
• W1965335179 hasLocation W19653351791 @default.
• W1965335179 hasLocation W19653351792 @default.
• W1965335179 hasLocation W19653351793 @default.
• W1965335179 hasLocation W19653351794 @default.

• next